BioMelbourne Network
Progressing BioIndustry
Ikaria Australia Pty Ltd
Website Address:
http://ikariaaust.com/
Corporate Member:
Dr Lorna Meldrum
Vice President & General Manager
Company Profile:
Ikaria is a biotherapeutics company whose therapies and research are directed to the significant unmet needs of critically ill patients. Ikaria’s drug development program focuses on endogenous signaling molecules such as (nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S)) which are powerful influencers of many cellular functions. Recent discoveries show that when these gases are delivered properly in low doses they may demonstrate essential critical care benefits.
INOMAX® (NO) for inhalation is Ikaria’s first commercialized product and is used to treat newborns suffering from hypoxic respiratory failure (HRF).
